Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing antifungal cyclic lipopeptide echinocandin B

A technology of echinocandin and cyclolipopeptide, which is applied in the field of preparation of antifungal cyclolipopeptide echinocandin B, can solve the problems of waste of solvent and difficulty in elution of by-products, reduce purification pressure and avoid degradation problems , the effect of small viscosity

Active Publication Date: 2018-03-09
LUNAN PHARMA GROUP CORPORATION
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] This application provides a preparation method of the antifungal cyclolipopeptide echinocandin B, which can simply and effectively solve the problems of difficult elution of by-products and waste of solvents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Take 100L of echinocandin B fermentation liquid (fermentation unit 743mg / L, mantumycin 153mg / L), add 100g of perlite, and collect echinocandin B bacterial cake by plate and frame filtration; fully soak the bacterial cake with 100L of 50% acetone , stirring and extracting for 1 hour, adding 500 g of activated carbon, and stirring for another 0.5 hour. Filter the extract with plate frame, collect the extract filtrate, detect ECB concentration as 725 mg / L, and mantramycin 0 mg / L. Add 150L of water, adjust the acetone concentration of the filtrate to 20%, put it on the ADS17 resin column (column bed volume 10L, aspect ratio 4:1), after the adsorption is complete, let it drain naturally. Heat 30L of anhydrous methanol to 50°C to elute the ADS17 resin. The eluent was concentrated to 15L under reduced pressure, added 15L of 5% NaCl aqueous solution, stirred and cooled to 2°C, a large amount of flocs were precipitated, vacuum filtered to obtain a crude echinocandin B wet cake,...

Embodiment 2

[0042]Take 100L of echinocandin B fermentation broth (705mg / L fermentation unit, 125mg / L mangutocin), add 100g of perlite, collect echinocandin B bacterial cake by plate and frame filtration; fully soak the bacterial cake with 100L of 80% acetone , stirring and extracting for 1 hour, adding 2000 g of activated carbon, and stirring for another 0.5 hour. The extract was plate-frame filtered, the extract filtrate was collected, and the concentration of ECB was detected to be 694 mg / L, and the concentration of mantramycin was 0 mg / L. Add 100L of water, adjust the acetone concentration of the filtrate to 40%, put it on the X-5 resin column (column bed volume 10L, aspect ratio 4:1), after the adsorption is complete, let it dry naturally. Heat 50L of anhydrous methanol to 50°C to elute the X-5 resin. The eluate was concentrated to 15L under reduced pressure, added 15L of 15% NaCl aqueous solution, stirred and cooled to 10°C, a large amount of flocs were precipitated, vacuum filtered...

Embodiment 3

[0044] Take 100L of echinocandin B fermentation liquid (fermentation unit 762mg / L, mantumycin 103mg / L), add 100g of perlite, and filter to collect echinocandin B bacteria cake; fully soak the bacteria cake with 100L of 40% acetone , stirring and extracting for 1 hour, adding 500 g of activated carbon, and stirring for another 0.5 hour. The extract was plate-frame filtered, the extract filtrate was collected, and the concentration of ECB was detected to be 648 mg / L, and the concentration of mantramycin was 0 mg / L. Add 100L of water, adjust the acetone concentration of the filtrate to 20%, put it on an ADS17 resin column (column bed volume 10L, aspect ratio 4:1), after the adsorption is complete, let it drain naturally. Heat 30L of anhydrous methanol to 50°C to elute the ADS17 resin. The eluate was concentrated to 15 L under reduced pressure, added 15 L of 5% NaCl aqueous solution, stirred and cooled to 2°C, a large amount of flocs were precipitated, vacuum filtered to obtain a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for preparing antifungal cyclic lipopeptide echinocandin B. The method comprises the following steps: 1) performing solid-liquid separation on an ECB (Echinocandin) fermentation broth; 2) enriching with a macroporous adsorption resin ADS-17 or X-5; 3) eluting the macroporous adsorption resin with hot absolute methyl alcohol, and combining eluants; 4) concentrating the eluants, adding a sodium chloride solution, stirring, cooling for crystal separation, and drying crude ECB filter cakes; 5) filtering the crude ECB filter cakes with methanol, and treating filtratewith a reverse phase resin column XT30; 6) concentrating the reverse phase resin column XT30 eluant, adding the sodium chloride solution, stirring, cooling for crystal separation, and drying ECB filter cakes; 7) collecting a dried ECB product. By adopting the method, the problems that byproducts are hard to elute and solvents are wasted are simply and effectively solved. Solid-liquid separation of water-containing ECB can be effectively completed, and product degradation is remarkably reduced. The method is simple and feasible and is applicable to industrial production, and the final purity of the echinocandin B is improved to 99% or greater.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a preparation method of an antifungal cyclolipopeptide echinocandin B. Background technique [0002] Echinocandins are a new generation of systemic antifungal drugs, the mechanism of action is to inhibit the activity of 1,3-β-D glucan synthase, thereby inhibiting the synthesis of fungal cell walls. Its unique action target and definite curative effect make it an important member of the antifungal drug family together with polyenes, triazoles and other drugs. [0003] The currently marketed drugs of this type include: caspofungin, micafungin, and anidifungin. Anifungin has no first-pass effect and is mainly used for the treatment of severe infections caused by Candida and Aspergillus. [0004] Anifungin is made from the fermentation product Echinocandin B (Echinocandin B, ECB), and the linoleic acid side chain is removed through chemical or enzymatic reactions to f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/56C07K1/36C07K1/30C07K1/22C07K1/18
CPCC07K7/56
Inventor 张贵民赵德立薛国希
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com